Arcus Biosciences, Inc. Capital Expenditures
Arcus Biosciences, Inc. (RCUS) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- Arcus Biosciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
- Arcus Biosciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Arcus Biosciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $1.00M, a 0.00% change year-over-year.
- Arcus Biosciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Arcus Biosciences, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $2.00M, a 66.67% decline from fiscal 2024.
- Arcus Biosciences, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $6.00M, a 75.00% decline from fiscal 2023.
- Arcus Biosciences, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $24.00M, a 300.00% increase from fiscal 2022.
- Arcus Biosciences, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $6.00M, a 76.92% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $1.00M derived: sum of 3 quarters · filed 2026-08-05 | $1.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $1.00M derived: sum of 2 quarters · filed 2026-05-05 | $1.00M derived: sum of 3 quarters · filed 2026-05-05 | $1.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.00M derived: sum of 2 quarters · filed 2026-02-25 | $1.00M derived: sum of 3 quarters · filed 2026-08-05 | $2.00M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $1.00M 10-Q · filed 2025-10-28 | $2.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.00M 10-Q · filed 2026-08-05 | $2.00M derived: sum of 3 quarters · filed 2026-08-05 | $3.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $1.00M 10-Q · filed 2026-05-05 | $2.00M derived: sum of 2 quarters · filed 2026-05-05 | $3.00M derived: sum of 3 quarters · filed 2026-05-05 | $3.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.00M derived: sum of 2 quarters · filed 2026-02-25 | $2.00M derived: sum of 3 quarters · filed 2026-02-25 | $6.00M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.00M derived: sum of 2 quarters · filed 2025-10-28 | $5.00M 10-Q · filed 2025-10-28 | $11.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $4.00M 10-Q · filed 2025-08-06 | $10.00M derived: sum of 3 quarters · filed 2026-02-25 | $20.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $4.00M 10-Q · filed 2025-05-06 | $10.00M derived: sum of 2 quarters · filed 2026-02-25 | $20.00M derived: sum of 3 quarters · filed 2026-02-25 | $25.00M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $16.00M derived: sum of 2 quarters · filed 2026-02-25 | $21.00M derived: sum of 3 quarters · filed 2026-02-25 | $24.00M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $15.00M derived: sum of 2 quarters · filed 2024-11-06 | $18.00M 10-Q · filed 2024-11-06 | $18.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $8.00M 10-Q · filed 2024-08-08 | $8.00M derived: sum of 3 quarters · filed 2025-02-25 | $10.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $3.00M 10-Q · filed 2024-05-08 | $3.00M derived: sum of 2 quarters · filed 2025-02-25 | $5.00M derived: sum of 3 quarters · filed 2025-02-25 | $6.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.00M derived: sum of 2 quarters · filed 2025-02-25 | $3.00M derived: sum of 3 quarters · filed 2025-02-25 | $6.00M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.00M derived: sum of 2 quarters · filed 2023-11-07 | $6.00M 10-Q · filed 2023-11-07 | $5.62M 10-Q · filed 2022-11-02 | $14.43M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $4.00M 10-Q · filed 2023-08-07 | $4.30M 10-Q · filed 2022-08-03 | $12.43M derived: sum of 3 quarters · filed 2024-02-21 | $20.29M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $3.00M 10-Q · filed 2023-05-09 | $2.79M 10-Q · filed 2022-05-09 | $11.43M derived: sum of 2 quarters · filed 2024-02-21 | $19.29M derived: sum of 3 quarters · filed 2024-02-21 | $25.36M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $8.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $16.29M derived: sum of 2 quarters · filed 2024-02-21 | $22.36M derived: sum of 3 quarters · filed 2024-02-21 | $26.00M 10-K · filed 2024-02-21 | $26.08M 10-K · filed 2022-02-23 | |||
| 2021-09-30 | $7.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $13.93M derived: sum of 2 quarters · filed 2022-11-02 | $17.57M 10-Q · filed 2022-11-02 | $19.04M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $9.71M 10-Q · filed 2022-08-03 | $11.18M derived: sum of 3 quarters · filed 2023-02-28 | $12.25M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $3.64M 10-Q · filed 2022-05-09 | $5.11M derived: sum of 2 quarters · filed 2023-02-28 | $6.18M derived: sum of 3 quarters · filed 2023-02-28 | $6.43M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $2.54M derived: sum of 2 quarters · filed 2023-02-28 | $2.79M derived: sum of 3 quarters · filed 2023-02-28 | $3.00M 10-K · filed 2023-02-28 | $3.06M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.33M derived: sum of 2 quarters · filed 2021-11-08 | $1.54M 10-Q · filed 2021-11-08 | $1.73M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $256.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $465.00K 10-Q · filed 2021-08-05 | $661.00K derived: sum of 3 quarters · filed 2022-02-23 | $1.21M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $209.00K 10-Q · filed 2021-05-05 | $405.00K derived: sum of 2 quarters · filed 2022-02-23 | $955.00K derived: sum of 3 quarters · filed 2022-02-23 | $1.51M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $196.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $746.00K derived: sum of 2 quarters · filed 2022-02-23 | $1.30M derived: sum of 3 quarters · filed 2022-02-23 | $1.93M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $550.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.10M derived: sum of 2 quarters · filed 2020-11-05 | $1.73M 10-Q · filed 2020-11-05 | $1.99M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $551.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.18M 10-Q · filed 2020-08-06 | $1.44M derived: sum of 3 quarters · filed 2021-02-25 | $2.56M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $628.00K 10-Q · filed 2020-05-05 | $886.00K derived: sum of 2 quarters · filed 2021-02-25 | $2.01M derived: sum of 3 quarters · filed 2021-02-25 | $3.32M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $258.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.39M derived: sum of 2 quarters · filed 2021-02-25 | $2.69M derived: sum of 3 quarters · filed 2021-02-25 | $3.74M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.43M derived: sum of 2 quarters · filed 2019-11-05 | $3.48M 10-Q · filed 2019-11-05 | $3.78M derived: sum of 4 quarters · filed 2019-11-05 | ||||
| 2018-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.36M 10-Q · filed 2019-08-06 | $2.65M derived: sum of 3 quarters · filed 2019-08-06 | $3.49M derived: sum of 4 quarters · filed 2019-08-06 | ||||
| 2018-03-31 | $1.05M 10-Q · filed 2019-05-02 | $1.35M derived: sum of 2 quarters · filed 2019-05-02 | $2.19M derived: sum of 3 quarters · filed 2019-05-02 | $4.43M derived: sum of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | $294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $1.13M derived: sum of 2 quarters · filed 2019-03-05 | $3.38M derived: sum of 3 quarters · filed 2019-03-05 | $5.51M 10-K · filed 2019-03-05 | ||||
| 2017-09-30 | $839.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.08M derived: sum of 2 quarters · filed 2018-11-08 | $5.22M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $4.38M 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | $2.14M 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | $4.10M 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |